Medicine and Dentistry
Glycosaminoglycan
100%
Diabetic Nephropathy
100%
Albuminuria
100%
Sulodexide
100%
Patient
100%
Diabetes Mellitus
75%
Therapeutic Procedure
75%
Combination Therapy
50%
Morbidity
50%
Metabolic Regulation
50%
ACE Inhibitor
50%
End Stage Renal Disease
50%
Mortality
50%
Microalbuminuria
50%
Macroalbuminuria
50%
Angiotensin Receptor Antagonist
50%
Cardiovascular System
25%
Health Care Cost
25%
Blood Pressure
25%
Vascular Disease
25%
Complications of Diabetes Mellitus
25%
Patient with Diabetes
25%
Drug
25%
Basement Membrane
25%
Chemotherapeutic Agent
25%
Endothelial Dysfunction
25%
Kidney Injury
25%
Consensus
25%
Inpatient
25%
Pharmacology, Toxicology and Pharmaceutical Science
Glycosaminoglycan
100%
Diabetic Nephropathy
100%
Sulodexide
100%
Albuminuria
100%
Diabetes Mellitus
75%
Dipeptidyl Carboxypeptidase Inhibitor
50%
Morbidity
50%
End Stage Renal Disease
50%
Angiotensin Receptor Antagonist
50%
Mortality
50%
Macroalbuminuria
50%
Microalbuminuria
50%
Vascular Disease
25%
Endothelial Dysfunction
25%
Drug
25%
Diabetic Complication
25%
Kidney Injury
25%
Biochemistry, Genetics and Molecular Biology
Glycosaminoglycan
100%
Sulodexide
100%
Metabolic Regulation
50%
Morbidity
50%
Mortality
50%
Glucose Blood Level
25%
Synthesis
25%
Experimental Model
25%
Blood Pressure
25%
Receptor Antagonist
25%
Basement Membrane
25%
Angiotensin Receptor
25%
Angiotensin
25%
Consensus
25%